Logo

Wyeth-Ayerst Opts For Oxford Molecular's RS3 Discovery System

Dec 22, 1998
Premium

OXFORD--Wyeth-Ayerst Research has signed a deal with Oxford Molecular Group to license and install Oxford's RS3 Discovery client/server information management system enterprise-wide. According to Oxford, the pharmaceutical company will use the system for chemical registration, structure and substructure searching, and integrating biological assay data through a common Oracle-RS3 Discovery server.

Filed under

Informatics
Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.